Topics
-
Highly Pathogenic Virus Therapeutics Development Team:Announcement on「Crimean-Congo hemorrhagic fever virus NSm protein inhibits the type I interferon signaling by binding to STAT2」 2025/11/4
-
Infectious Disease Medical Epidemiology Team:Announcement on「Infectious Disease Medical Epidemiology Team:Announcement on Continuing to be cautious: Japanese contact patterns during the COVID-19 pandemic and their association with public health recommendations」 2025/9/24
-
Infectious Disease Medical Epidemiology Team:Announcement on「Stakeholder meeting report: Chikungunya virus – recent outbreaks, vaccine development and the way forward」 2025/9/19
-
Infectious Disease Medical Epidemiology Team:Announcement on「Disentangling temporal trends of clade Ib monkeypox virus transmission in Burundi」 2025/9/10
-
Infectious Disease Medical Epidemiology Team:Announcement on 「Vaccination strategies to achieve outbreak control for MPXV Clade I with a one-time mass campaign in sub-Saharan Africa: A scenario-based modelling study」 2025/9/5
-
Parasitic Disease Drug Development Team:Announcement on 「A pseudokinase pPK4 is required for efficient red blood cell invasion and exflagellation center formation in Plasmodium yoelii」 2025/10/24
-
Infectious Disease Medical Epidemiology Team:Announcement on 「Global, regional and national burden of chikungunya: force of infection mapping and spatial modelling study」 2025/10/1
-
VRDC Newsletter Vol.3 has been released.
-
Tropical Virus Pharmaceutical Research Team:Announcement on「Molecular and Serological Detection of Zika Virus and Zika–Dengue Virus Coinfections in Febrile Patients in Sabah, Malaysia, 2019–2020」 2025/10/9
-
Tropical Virus Pharmaceutical Research Team:Announcement on 「Epidemiological insights into the co-circulation of Zika and dengue viruses in Yangon, Myanmar (2017-2019)」 2025/9/24



